These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15050954)

  • 1. Role of transforming growth factor beta in breast carcinogenesis.
    Benson JR
    Lancet Oncol; 2004 Apr; 5(4):229-39. PubMed ID: 15050954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the transforming growth factor-beta signalling pathway in metastatic cancer.
    Korpal M; Kang Y
    Eur J Cancer; 2010 May; 46(7):1232-40. PubMed ID: 20307969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-beta-induced upregulation of MMP-2 and MMP-9 depends on p38 MAPK, but not ERK signaling in MCF10A human breast epithelial cells.
    Kim ES; Kim MS; Moon A
    Int J Oncol; 2004 Nov; 25(5):1375-82. PubMed ID: 15492828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer.
    Bierie B; Moses HL
    Nat Rev Cancer; 2006 Jul; 6(7):506-20. PubMed ID: 16794634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The roles of TGF-β signaling in carcinogenesis and breast cancer metastasis.
    Imamura T; Hikita A; Inoue Y
    Breast Cancer; 2012 Apr; 19(2):118-24. PubMed ID: 22139728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways.
    Janda E; Lehmann K; Killisch I; Jechlinger M; Herzig M; Downward J; Beug H; Grünert S
    J Cell Biol; 2002 Jan; 156(2):299-313. PubMed ID: 11790801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained TGF beta exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis.
    Gal A; Sjöblom T; Fedorova L; Imreh S; Beug H; Moustakas A
    Oncogene; 2008 Feb; 27(9):1218-30. PubMed ID: 17724470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic profiling identifies alterations in TGFbeta signaling through loss of TGFbeta receptor expression in human renal cell carcinogenesis and progression.
    Copland JA; Luxon BA; Ajani L; Maity T; Campagnaro E; Guo H; LeGrand SN; Tamboli P; Wood CG
    Oncogene; 2003 Sep; 22(39):8053-62. PubMed ID: 12970754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual role of transforming growth factor beta in mammary tumorigenesis and metastatic progression.
    Muraoka-Cook RS; Dumont N; Arteaga CL
    Clin Cancer Res; 2005 Jan; 11(2 Pt 2):937s-43s. PubMed ID: 15701890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of TGFbeta in metastasis.
    Padua D; Massagué J
    Cell Res; 2009 Jan; 19(1):89-102. PubMed ID: 19050696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of TGFbeta signaling in skin carcinogenesis.
    Wang XJ
    Microsc Res Tech; 2001 Feb; 52(4):420-9. PubMed ID: 11170301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role for transforming growth factor-beta (TGF-beta) in human cancer.
    Gold LI
    Crit Rev Oncog; 1999; 10(4):303-60. PubMed ID: 10654929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of responsiveness to transforming growth factor beta induces malignant transformation of nontumorigenic rat prostate epithelial cells.
    Tang B; de Castro K; Barnes HE; Parks WT; Stewart L; Böttinger EP; Danielpour D; Wakefield LM
    Cancer Res; 1999 Oct; 59(19):4834-42. PubMed ID: 10519393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dynamic roles of TGF-β in cancer.
    Meulmeester E; Ten Dijke P
    J Pathol; 2011 Jan; 223(2):205-18. PubMed ID: 20957627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGFbeta-regulated transcriptional mechanisms in cancer.
    Ellenrieder V; Buck A; Gress TM
    Int J Gastrointest Cancer; 2002; 31(1-3):61-9. PubMed ID: 12622416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells.
    Wang J; Yang L; Yang J; Kuropatwinski K; Wang W; Liu XQ; Hauser J; Brattain MG
    Cancer Res; 2008 May; 68(9):3152-60. PubMed ID: 18451140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness.
    Gaspar NJ; Li L; Kapoun AM; Medicherla S; Reddy M; Li G; O'Young G; Quon D; Henson M; Damm DL; Muiru GT; Murphy A; Higgins LS; Chakravarty S; Wong DH
    Mol Pharmacol; 2007 Jul; 72(1):152-61. PubMed ID: 17400764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of growth regulation by transforming growth factor-beta (TGF-beta) in human cancers: studies on endometrial carcinoma.
    Gold LI; Parekh TV
    Semin Reprod Endocrinol; 1999; 17(1):73-92. PubMed ID: 10406078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells.
    Deckers M; van Dinther M; Buijs J; Que I; Löwik C; van der Pluijm G; ten Dijke P
    Cancer Res; 2006 Feb; 66(4):2202-9. PubMed ID: 16489022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of epithelial-mesenchymal transition by transforming growth factor β.
    Moustakas A; Heldin CH
    Semin Cancer Biol; 2012 Oct; 22(5-6):446-54. PubMed ID: 22548724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.